Inhibition of ABC Transporters Abolishes Antimony Resistance inLeishmaniaInfection
- 1 March 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (3), 1080-1093
- https://doi.org/10.1128/aac.01196-07
Abstract
The emergence of antimony (Sb) resistance has jeopardized the treatment of visceral leishmaniasis in various countries. Previous studies have considered the part played by leishmanial parasites in antimony resistance, but the involvement of host factors in the clinical scenario remained to be investigated. Here we show that unlike infection with Sb-sensitive (Sbs)Leishmania donovani, infection with Sb-resistant (Sbr)L. donovaniinduces the upregulation of multidrug resistance-associated protein 1 (MRP1) and permeability glycoprotein (P-gp) in host cells, resulting in a nonaccumulation of intracellular Sb following treatment with sodium antimony gluconate (SAG) favoring parasite replication. The inhibition of MRP1 and P-gp with resistance-modifying agents such as lovastatin allows Sb accumulation and parasite killing within macrophages and offers protection in an animal model in which infection with SbrL. donovaniis otherwise lethal. The occurrence of a similar scenario in clinical cases is supported by the findings that unlike monocytes from SAG-sensitive kala-azar (KA) patients, monocytes from SAG-unresponsive KA patients overexpress P-gp and MRP1 and fail to accumulate Sb following in vitro SAG treatment unless pretreated with inhibitors of ABC transporters. Thus, the expression status of MRP1 and P-gp in blood monocytes may be used as a diagnostic marker for Sb resistance and the treatment strategy can be designed accordingly. Our results also indicate that lovastatin, which can inhibit both P-gp and MRP1, might be beneficial for reverting Sb resistance in leishmaniasis as well as drug resistance in other clinical situations, including cancer.Keywords
This publication has 54 references indexed in Scilit:
- A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell DeathMolecular & Cellular Proteomics, 2007
- Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome SerologyPLOS ONE, 2006
- Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated ApoptosisClinical Cancer Research, 2006
- Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation inLeishmania donovani-Infected MacrophagesAntimicrobial Agents and Chemotherapy, 2006
- Mechanisms of Drug Resistance in Cancer ChemotherapyMedical Principles and Practice, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Kala-Azar as an AIDS-Related Opportunistic InfectionAIDS Patient Care and STDs, 1999
- A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.JCI Insight, 1998
- ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletionFEBS Letters, 1995
- Mycobacterium tuberculosis Induces Expression of P-Glycoprotein in Promonocytic U1 Cells Chronically Infected with HIV Type 1Biochemical and Biophysical Research Communications, 1994